Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not for nothing but we are not in the 2s anymore . We are mid 3s with a merger around the corner. These 3s will be a rarity soon , so if you want them , grab them ..imo
We got a Nhod boys,, LFG
Yep, it will go, it's been moving organically with fairly slim volume,once a real catalyst hits we are in for a big time move, and I'm not even talking about the Merger. That should get us plus 5 easy imo
I'm with you on that thought Dino, but I think that $10 is just for starters, maybe 20 to 30 in a few months if they play their cards right ,,which I think will happen.
New filing out
This is realistic
Added 2.40s
Added 2.48s
After watching that video I think we see $20 plus in 2 plus months... imo
Added 2.83s
I added the dip, ignore the noise
Imminent...any day now
Anyone else see that 1.3m bid currently at .2827
It could as good as .42
Looks like some Form 4s hit last night showing insider buying shares
As my cat says .. meoowt
News out boys and girls
Yeah I bought half those shares but they didn't show up for an hour
Compliance!!!
Added a few thousand shares this am but it shows no volume..
Indeed
Me at .85
Hmmm a little action today
It just hit
On that note, I added again this am
$VIRI
— Frank_Benedetto (@FrankieBstock) April 17, 2024
They keep on highlighting this..are they foreshadowing or begging? 🤔 https://t.co/xtSKqZwBMF
JAGX average was .07 it crossed .25
Now .45s added
Added .46s to me stash, these bios have a tendency to go ballistic without notice, like what one of mine did today
What's up
Gelclair is an FDA-approved prescription product and can be commercialized without any clinical development costs for Jaguar," added Conte. "We are expanding our footprint beyond HIV-related supportive care to include cancer-related supportive care, and the in-license of Gelclair is a first building block while we await the forthcoming results from our pivotal Phase 3 OnTarget trial of crofelemer for cancer therapy-related diarrhea, an indication we also refer to as chemotherapy-
Added a tad more this am
Here we go Action
These Bios are quiet until they are not..
Added .46s !!!
I like
I added .46s...
That's a nice target.!!
What's happening at 2:45 .. are you referring to power hour?